Yang JJ - Search Results

1

The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC.

Liu SY, Gou LY, Li AN, Lou NN, Gao HF, Su J, Yang JJ, Zhang XC, Shao Y, Dong ZY, Zhou Q, Zhong WZ, Wu YL. Liu SY, et al. Among authors: yang jj. J Thorac Oncol. 2016 Sep;11(9):1503-10. doi: 10.1016/j.jtho.2016.05.016. Epub 2016 May 30. J Thorac Oncol. 2016. PMID: 27257131 Free article.

2

Pre- and postoperative sequential study on the immunosuppressive activity of serum and cell-free skin bleb fluid of patients with lung cancer and esophageal cancer.

Zhou QH, Yang ZH, Zhang HB, Yang JJ, Xiao YK. Zhou QH, et al. Among authors: yang zh, yang jj. J Surg Oncol. 1989 Jun;41(2):121-7. doi: 10.1002/jso.2930410213. J Surg Oncol. 1989. PMID: 2724979

3

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].

Xu CR, Lin JY, Wang Z, Zhou Q, Zhang GC, Wang K, Yang XN, Chen G, Yang JJ, Huang YJ, Liao RQ, Wu YL. Xu CR, et al. Among authors: yang xn, yang jj. Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2606-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17198584 Chinese.

4

[Gefitinib target treatment in non-small cell lung cancer].

Wu YL, Yang JJ, Lin JY, Huang YJ, Liao RQ, Huang YS, Zhou Q, Xu CR, Wang Z. Wu YL, et al. Among authors: yang jj. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):98-102. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17445469 Clinical Trial. Chinese.

5

Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.

Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Zhong W, et al. Eur J Cardiothorac Surg. 2008 Jul;34(1):187-95. doi: 10.1016/j.ejcts.2008.03.060. Epub 2008 May 23. Eur J Cardiothorac Surg. 2008. PMID: 18457958 Review.

6

Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.

Zhong WZ, Wu YL, Yang XN, Guo AL, Su J, Zhang XC, Luo DL, Wang Z, Chen HJ, Zhou Q, Xu CR, Qiao GB, Liao RQ, Yang JJ, Mok TS. Zhong WZ, et al. Among authors: yang xn, yang jj. Clin Lung Cancer. 2010 May;11(3):160-8. doi: 10.3816/CLC.2010.n.020. Clin Lung Cancer. 2010. PMID: 20439191

7

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.

Zhang X, Zhang S, Yang X, Yang J, Zhou Q, Yin L, An S, Lin J, Chen S, Xie Z, Zhu M, Zhang X, Wu YL. Zhang X, et al. Mol Cancer. 2010 Jul 13;9:188. doi: 10.1186/1476-4598-9-188. Mol Cancer. 2010. PMID: 20624322 Free PMC article.

8

[Erlotinib in the Second/Third Line Treatment of Patients with Advanced Non-small Cell Lung Cancer.].

Huang Y, Yang J, Huang Y, Xu C, Zhou Q, Wang Z, Wu Y. Huang Y, et al. Zhongguo Fei Ai Za Zhi. 2009 May 20;12(5):412-6. doi: 10.3779/j.issn.1009-3419.2009.05.019. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719136 Free article. Chinese.

9

[Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefinitib.].

Yang X, Zhang X, Yang J, Huang Y, Guo A, Lin J, An S, Tang H, Cheng S, Huang Y, Wu Y. Yang X, et al. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):765-9. doi: 10.3779/j.issn.1009-3419.2009.07.018. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719152 Free article. Chinese.

10

[The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer.].

Huang Y, Yang J, Yang Y, Huang Y, Liao R, Wu Y. Huang Y, et al. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1266-70. doi: 10.3779/j.issn.1009-3419.2009.12.08. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723381 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,179 results

Search Page